Show simple item record

dc.contributor.authorKleynhans, Janke
dc.contributor.authorGrobler, Anne Frederica
dc.contributor.authorZeevaart, Jan Rijn
dc.contributor.authorEbenhan, Thomas
dc.contributor.authorSathekge, Mike Machaba
dc.date.accessioned2018-09-26T06:53:57Z
dc.date.available2018-09-26T06:53:57Z
dc.date.issued2018
dc.identifier.citationKleynhans, J. et al. 2018. Radiopharmaceutical enhancement by drug delivery systems: a review. Journal of controlled release, 287:177-193. [https://doi.org/10.1016/j.jconrel.2018.08.008]en_US
dc.identifier.issn0168-3659
dc.identifier.issn1873-4995 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/31112
dc.identifier.urihttps://doi.org/10.1016/j.jconrel.2018.08.008
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0168365918304619
dc.description.abstractIntroduction Drug delivery systems are entities designed to alter the biological behaviour of the pharmaceutical active ingredients that they carry in order to afford more beneficial biodistribution and safety profiles. Many problems currently faced by the field of nuclear medicine (e.g. developing new theranostic agents, utilizing multimodal imaging platforms and providing targeted delivery) can be facilitated by applying drug delivery systems to radiopharmaceuticals that have been proven successful in other medical fields. This review describes the advancements being made towards this goal. Areas covered All aspects of drug delivery systems (liposomes, nanoparticles, microspheres) in the field of nuclear medicine are discussed. Only systems with foreseen or confirmed clinical applications in nuclear medicine are discussed, not instances where nuclear imaging is merely a tool to evaluate the biodistribution of novel delivery technologies. Conclusion Great advancements have been made with the development of novel systems incorporating nuclear entities in drug delivery systems, with the possibility of reshaping the nuclear medicine landscape. Nonetheless, translation from preclinical evaluations to clinical use is lacking and serious investment needs to be made towards this goal.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectNuclear medicineen_US
dc.subjectDrug carrier systemsen_US
dc.subjectRadiopharmaceuticalsen_US
dc.subjectTheranosticsen_US
dc.subjectMulti-modality imagingen_US
dc.titleRadiopharmaceutical enhancement by drug delivery systems: a reviewen_US
dc.typeArticleen_US
dc.contributor.researchID11008857 - Grobler, Anne Frederica
dc.contributor.researchID16951484 - Zeevaart, Jan Rijn
dc.contributor.researchID21090955 - Kleynhans, Janke


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record